ClinConnect ClinConnect Logo
Search / Trial NCT00704743

A Trial Comparing Circumferential Casting Versus Splinting in Displaced Colles' Fractures

Launched by UNIVERSITY OF BRITISH COLUMBIA · Jun 24, 2008

Trial Information

Current as of August 24, 2025

Completed

Keywords

Colles Fracture Treatment Displaced Fracture Of Distal Radius Distal Radius Fracture Treatment Rct Emergency Department Cast Splint Treatment

ClinConnect Summary

Primary: To determine the effectiveness of three immobilization methods (circumferential cast \[CC\], volar dorsal splint \[VDS\], modified sugar-tong \[MST\] splint) in maintaining the position of displaced distal radius fractures after successful closed reduction.

Secondary to assess long term functional outcomes associated with fiberglass splint immobilization versus standard cylindrical casting in patients maintaining initial non-operative reductions.

Design: Randomized prospective single blind controlled trial Patients/Participants: Patients over 18 years of age who presented to the ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \> 18 years
  • Displaced fracture of distal radius requiring closed reduction
  • Exclusion Criteria:
  • Open fracture
  • Previous displaced fracture involving the same or contralateral distal radius
  • neuromuscular deficits or CVA of either upper extremity that impaired functional outcome assessment
  • concurrent carpal bone fractures or dislocations - - unstable fractures requiring primary open reduction and internal fixation
  • skin allergy or sensitivity to either of the immobilization materials
  • Smith's, Barton's or Chauffeur fractures
  • Neurovascular compromise of the affected limb - - Bilateral distal radius fractures that prevented follow-up comparison with a normal contralateral limb
  • Other significant and concurrent injuries in the ipsilateral extremity.
  • Undisplaced distal radius fracture
  • Reduction performed in the ED did not meet criteria for successful fracture reduction

About University Of British Columbia

The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.

Locations

Vancouver, British Columbia, Canada

Patients applied

0 patients applied

Trial Officials

Robert Stenstrom, MD, Ph.D

Principal Investigator

University of British Columbia

Eric Grafstein, MD

Study Director

University of British Columbia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials